We deliver bold and effective solutions at the intersection of patient advocacy and life science innovation

The global healthcare landscape has evolved to become more patient centric. It is critical for life science innovators to infuse perspective from their target patient communities early, often and in real-time.

At Patient Advocacy Strategies, we're like you: Thoughtful, strategic, and moving with purpose & urgency to bring meaningful, disruptive innovation and solutions to those who need it most.

With decades of industry experience, we efficiently operationalize your patient engagement efforts at every stage of the drug development continuum to maximize the value you create for patients.

Here are just a few of the forward-thinking life science companies we've been proud to call clients

Amplified patient perspectives infuse immeasurable value into virtually all functional areas of a life science organization.

Let's Work Together

For Patient Engagement Teams:

A thoughtful & integrated patient advocacy strategy serves as the roadmap for Patient Advocacy personnel to harness the patient perspective, generating valuable insights internally and demonstrating corporate leadership with disease communities externally.

We establish and enhance your position as the central point of contact and face of your organization with patient communities to provide a feedback loop on patient input to enrich the work of your cross-functional partners.

Our seasoned team of patient advocates and industry patient engagement veterans are poised to support you in flawlessly implementing patient advocacy strategies both internally and externally.

For Medical affairs:

Disease-specific engagement with patient communities supports Medical Affairs initiatives in equipping the team with direct, high-touch access to the entire disease state universe of stakeholders involved in a particular health condition.

Harness the entirety of a targeted disease community, including KOLs, providers, patient leaders, and patient advocacy organizations to inform and align with your Med Affairs agenda.

For Clinical Operations:

Proactive partnerships with patient communities and advocacy organizations supports the Clinical Operations function with targeted clinical trial educational materials, outreach strategies, and trial design.

Collaboration with patients will directly support protocol development, patient-facing materials, trial accessibility considerations and patient support to accelerate enrollment and enhance study retention.

For Commercial:

Proactively establishes an advocacy-focused strategy that puts patients at the forefront of commercialization infrastructure to execute a targeted plan that is centered around patients' unmet medical needs. 

PAS fuels your commercialization and brand planning initiatives to engage the true end consumer of your product, ensuring messages, tactics and metrics are validated by the patients to whom you serve.

For Corporate Communications/IR:

Infuses patient voice into company messaging through co-developed disease-relevant information while elevating corporate profile. Patient voice validates corporate leadership role within disease community.

Reflect and adapt the patient voice to be appropriate for each key audience through all company communications, including press releases, investor communications and community engagement.

For Market Access:

Proactive engagement with patient community influencers arms you with independent champions to amplify the value of innovation in addressing health needs..

We harness the patient voice to inform coverage and reimbursement discussions to broaden formulary and patient access policy to enable the appropriate patient receives the best treatment option.

Proactive & coordinated patient advocacy to engage in ICER and HTA value assessment exercises to ensure the patient voice is clearly and effectively integrated into pricing and access decisions.

We build solutions at the intersection of patient advocacy and the life sciences.

Our Approach

Flexible, agile strategies built for your team's unique needs.

"With the increasing commitment to Patient-Focused Drug Development and patient engagement in translational research, a significant opportunity exists to improve the clinical trials enterprise and enhance participation by patient groups" -- Clinical Trials Transformation Initiative Recommendations; Patient Groups & Clinical  Trials 2020
Our team brings with us extensive and diverse backgrounds steeped in the life sciences, patient advocacy, public health, corporate communications, design, web development, and more to forge ironclad partnerships with targeted disease leaders.


We are thought leaders in patient engagement and possess strong, collaborative & trusted relationships with patient advocacy communities. Patient Advocacy Strategies is uniquely equipped to not only craft purpose-built engagement initiatives for your team's immediate needs, but to drive those initiatives all the way from concept to market launch.

Patient Advocacy Strategies encompasses three major practices: Strategies, Studio, and Synthesis.

These wide-ranging, in-house capabilities enable the PAS team to fully scope, plan, refine and execute unique patient-engaging initiatives from concept to campaign completion.
Get in touch

Customized and Strategic Patient Engagement

The foundation for strategy development begins at the convergence of business objectives and patient needs. Under PAS leadership, the patient voice is effectively integrated to enrich the value creation of the drug development process as you evolve your corporate strategy.
Learn about Strategies

Core Functions

Strategy Development
Crafts the roadmap for engagement to inform trial parameters, endpoints, meaningful patient experience improvements
Disease Landscape Analysis
Maps the disease universe of influencers, prioritizes outreach in a coordinated and thoughtful manner to introduce you to your customers.
Insights and data gathered exposes study logistical considerations of your therapy, trial design, and patient burden
Stakeholder Development & Coalition Building
Earns authentic trust, ongoing two-way communication that Increases patient engagement with and accessibility to your research
Non-Profit Advocacy Organization Leadership
Builds your team's patient network and provides an early start to upcoming clinical recruitment and unlocks the perspectives to add insight to your activities.

Creative Development Designed For Patient Engagement

Every executed strategy benefits from eye-catching and impactful creative content, developed through patient insights that uncover patient needs.
From branding to patient education materials, PA Studio can bring patient-facing concepts to vivid life, with realtime input to guide your efforts.
Learn about Studio

Core Functions

Brand Identity Development
With ongoing input from targeted patient communities, corporate and brand narratives are targeted to address the needs of the patients, providers and caregivers you seek to serve.
Patient-facing Websites + Digital Experiences
Resources developed with ongoing disease stakeholder input to educate, empower and engage patients to learn about health conditions & clinical trials and compel them to make the most informed health decisions will showcase your company as a corporate citizen dedicated to making their lives better through enhanced health outcomes and improved quality of life.
Infographics + Data Visualizations
Co-developed materials with patient voice integrated translates complex science to meaningful value for patients with unmet health needs.
Patient-Ready Content
Trusted alliances with disease communities strengthens your team's patient network and provides an engaged, educated and captive audience to drive your clinical programs, corporate image and brand forward.

Build a 360 Degree View of Your Patient Landscape

Distill the most important details regarding your target patient communities into actionable insights and next steps.
Learn about Synthesis

Core Functions

Social Listening
Establishes a baseline understanding of patient impressions, trial and brand identity and uncovers opportunities to define the narrative in support of disease community & patient needs
Competitive Landscape Analysis
Comprehensive stakeholder landscape assessments identify all entities active in targeted patient communities, uncovering met and unmet needs to create opportunities to engage.
Bespoke Data Reporting
Monitors your engagement, education, public sentiment and evolution of corporate perception by your target patient audience in realtime.
Digital Patient Surveys
Disease survey platforms reveal deep insights into patient journey and answers every question your organization has about patient needs to inform your strategy.
Patient Focus Groups
PAS convenes active listening sessions with targeted audiences to dive deeper to understand where the true opportunity exists to address unmet patient needs.

patient engagement timeline

Early engagement with patients can lead to a greater than 500x return on investment.

Regardless of where your clinical programs stand in development, it's never too early to engage your target patient communities to uncover valuable insights and begin to earn authentic trust.

PAS delivers long-standing patient advocacy relationships and vast experience in crafting customized engagement solutions for teams at every phase of the R&D continuum to accelerate the scoping and implementation of your team's patient outreach strategies.

Where in the research pipeline is your team?

Click on the stage most relevant to your team's pipeline here to find some of the various ways we can help you engage with patients.
How can we help?

Capabilities for
Pre-clinical Stage Engagement

Patient insights
Data capture and survey queries expose detailed feedback regarding general disease perspectives, and more specific feedback to inform clinical trial considerations, patient-influenced meaningful endpoints & exposure to overall patient experience and patient and caregiver journey
Patient advisory sessions
PAS roundtables can provide valuable input to virtually any question your organization has around the needs of a patient population. Start broad to achieve a general, baseline understanding of what it's like to live with a certain condition or dive deep to exploit and understand a specific facet of a complex medical condition
Patient co-created materials + patient-ready research materials
Increases patient engagement with and accessibility to your research
Contact list building
Builds your team's patient network and provides an early start to upcoming clinical recruitment
Patient participation in external communications
Provides a patient perspective to inform your team's communications with investors, advocacy groups, and other external stakeholders
Dedicated patient-facing webpages
Creates a branded or unbranded online community for your patient and caregiver communities to drive trial demand and enrollment, educate about a little-known condition or amplify the narrative that fits your strategy.

Capabilities for
Clinical Stage Engagement

Clinical trial webpages
Provides key patient and caregiver demographics easy, online access to your studies
Branded and Unbranded Educational Materials Creation
Provides accessible, easy-to-understand, and engaging materials to better inform your patient and caregiver communities
Social Media Engagement Campaigns
With patient advocates and patient advocacy groups, social media engagement creates and increases online awareness about your trial
Patient Advisory Groups
Provides your team the opportunity to review key materials, trial design, and patient outreach opportunities with diverse, representative patients and caregivers
Individual Engagement with Patient Influencers
Individualized, custom engagement with key patient influencers in your team's key indications provide the opportunity to build grassroots relationships and drive awareness through trusted members of your patient communities

Capabilities for
FDA Review and Approval Stage Engagement

Patient insights
Informs trial parameters, endpoints, meaningful patient experience improvements
Patient advisory sessions
Exposes study logistical considerations of your therapy, trial design, and patient burden
Patient co-created materials + patient-ready research materials
Increases patient engagement with and accessibility to your research
Contact list building
Builds your team's patient network and provides an early start to upcoming clinical recruitment
Patient participation in external communications
Provides a patient perspective in your team's communications with investors, advocacy groups, and other external stakeholders
Dedicated patient-facing webpages
Creates a branded or unbranded online community for your patient and caregiver communities

Capabilities for
Commercialization Stage Engagement

Patient insights
Informs trial parameters, endpoints, meaningful patient experience improvements
Patient advisory sessions
Exposes study logistical considerations of your therapy, trial design, and patient burden
Patient co-created materials + patient-ready research materials
Increases patient engagement with and accessibility to your research
Contact list building
Builds your team's patient network and provides an early start to upcoming clinical recruitment
Patient participation in external communications
Provides a patient perspective in your team's communications with investors, advocacy groups, and other external stakeholders
Dedicated patient-facing webpages
Creates a branded or unbranded online community for your patient and caregiver communities

Global Launch of a New Rare Blood Cancer Therapeutic

Create a coalition model to galvanize the largely fragmented pre-partum and post-partum mental health community.
Read more ⟶

Measuring Patient Landscape in Niche women's Health

Create a coalition model to galvanize the largely fragmented pre-partum and post-partum mental health community.
Read more ⟶

From our latest white paper

What can $100,000 do for your commercial pipeline?

How can patient engagement accelerate commercialization timelines? What is the impact of avoiding a costly protocol amendment? And how can your team ensure your patient engagement tactics are built to generate these sorts of measurable results?

In our latest Synthesis report, we dive deep into research that demonstrates what kind of impact a $100,000 investment in early patient engagement activities could have on a team's clinical research pipeline and timelines to commercialization.
Read the Report

2.5 years

Measured acceleration of a pre-phase 2 product launch due to early patient engagement

$62 million

Increase in net present value of a commercialized drug due to clinical operations boost from early patient engagement

500x

Return on investment on a $100,000 budget allocated to early patient engagement

More Insights from the Intersection of Advocacy and Research

Synthesis is a regularly-updated set of industry reports designed for life sciences professionals who wish to bring the impact of patient advocacy into their organizations.
Read the Reports

Patient Advocacy Strategies encompasses three major practices: Strategies, Studio & Synthesis.

Between these in-house teams, the Patient Advocacy Strategies team can fully scope, plan, create, and execute unique patient-engaging initiatives from concept to campaign completion.

Best-in-class patient engagement

The foundation for strategy development begins at the convergence of business objectives and patient needs. Under PAS leadership, the patient voice is effectively integrated to enrich the value creation of the drug development process.
Learn More about strategies

Strategy Development

The foundation for strategy development begins at the convergence of business objectives and patient needs

Disease Landscape Analysis

Our vast network of patient and disease stakeholders enables us to map the most effective influencers with a health condition and therapeutic area

Patient Testimony

PAS brings over two decades of experience working with patient communities to optimize the narrative that amplifies what it is like to live with a health condition

Stakeholder Development and Coalition Building

PAS strategically aligns and engages diverse stakeholders with common objectives to galvanize collective action to achieve mutual goals

Non-Profit Advocacy Organization Leadership

PAS brings a wealth of experience leading patient advocacy organizations, charitable and philanthropic foundations to maximize resources to advance their purpose

Public Policy Advocacy

PAS builds alliances with disease leaders and influencers to construct policies that maximizes patient access to high-quality care to improve health outcomes

Score

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.

Creative Development Designed For Patient Engagement

The foundation for strategy development begins at the convergence of business objectives and patient needs. Under PAS leadership, the patient voice is effectively integrated to enrich the value creation of the drug development process.
Learn More about Studio

Creative Development

The foundation for strategy development begins at the convergence of business objectives and patient needs.

Brand Identity

Our vast network of patient and disease stakeholders enables us to map the most effective influencers with a health condition and therapeutic area

Web Development

PAS brings over two decades of experience working with patient communities to optimize the narrative that amplifies what it is like to live with a health condition

Content Creation

PAS strategically aligns and engages diverse stakeholders with common objectives to galvanize collective action to achieve mutual goals

Print Design

PAS brings a wealth of experience leading patient advocacy organizations, charitable and philanthropic foundations to maximize resources to advance their purpose

Data Visualizations

PAS builds alliances with disease leaders and influencers to construct policies that maximizes patient access to high-quality care to improve health outcomes

Score

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.

Best-in-class patient engagement

The foundation for strategy development begins at the convergence of business objectives and patient needs. Under PAS leadership, the patient voice is effectively integrated to enrich the value creation of the drug development process.
Learn More about strategies

Social Listening

The foundation for strategy development begins at the convergence of business objectives and patient needs.

Digital Landscape Analysis

Our vast network of patient and disease stakeholders enables us to map the most effective influencers with a health condition and therapeutic area

Competitive Landscape Analysis

PAS brings over two decades of experience working with patient communities to optimize the narrative that amplifies what it is like to live with a health condition

Bespoke Data Reporting

PAS strategically aligns and engages diverse stakeholders with common objectives to galvanize collective action to achieve mutual goals

Patient Landscape Surveys

PAS brings a wealth of experience leading patient advocacy organizations, charitable and philanthropic foundations to maximize resources to advance their purpose

Score

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.

Partner Testimonials

Patient Advocacy Strategies has uniquely established themselves as pioneers in this important space and will add great value to any company and any patient community, and through this dialogue help accelerate medical innovation and the development of novel treatments.

Robert Coughlin
Former President & CEO
MassBio



Mike and his team's passion, authenticity and relationship management skills earned him strong credibility and leadership among a variety of patient and professional stakeholders, societies, and healthcare policy organizations.

Mike sees the “big picture,” and knows how to work backwards to execute strategic plans that make tremendous and meaningful change.  A rare talent indeed, Mike inspires the best in others, always having his compass set on delivering superior results for both clients and the patients they serve.

Carolyn TenEyck, RN
Sr. Director, Advocacy & Government Affairs
Prolacta Bioscience

Mike Walsh is the ultimate patient advocate.

Based on my experience working with him during his time at Genentech, I can honestly say I have never met anyone who was more focused and driven to help patients who suffered with lung fibrosis. His innovative ideas are part of the reason patients with lung fibrosis are having more positive outcomes.

Mary Salvatore MD, MBA
Associate Professor, Radiology
Columbia University Irving Medical Center

wAIHA Warriors would not be the resource it is today for patients with warm Autoimmune Hemolytic Anemia without the expertise of Mike, Kelly, and Terri of Patient Advocacy Strategies.

Experiencing a rare disease has unique obstacles. Even far more discouraging than a challenging path to diagnosis, fewer specialists who agree on the best course of treatment, and an uncertain future of recurrences, is the lack of public awareness, resulting in fewer educational resources and a non-existent community of support.

By including patients, medical experts, and clinical researchers in their strategic vision, PAS created a new landscape of learning about wAIHA. With the development of the wAIHA website and an extensive social media presence, Patient Advocacy Strategies has elevated wAIHA Warriors as the leading resource for educational information, clinical trials, and mental health assistance materials as patients navigate this rare disease.

Karen Jones
Patient advisory board member
wAIHA Warriors

Patient Advocacy Synthesis

Access the latest patient advocacy and industry insights, as synthesized by our team.

How Early Patient Engagement Leads to a greater than 500x rOI

Read our detailed breakdown ⟶

New FDA Guidance: Patient Engagement

Read our detailed breakdown ⟶

New FDA Guidance: Patient Engagement

Read our detailed breakdown ⟶

New FDA Guidance:
Patient Engagement

What the new FDA paper means for your team, and how you can best leverage the newest guidance. A breakdown of the details here.
Read our detailed breakdown ⟶

New FDA Guidance:
Patient Engagement

What the new FDA paper means for your team, and how you can best leverage the newest guidance. A breakdown of the details here.
Read our detailed breakdown ⟶

New FDA Guidance:
Patient Engagement

What the new FDA paper means for your team, and how you can best leverage the newest guidance. A breakdown of the details here.
Read our detailed breakdown ⟶

Access All Patient Advocacy Strategies Insights

PA Scores

This is some text inside of a div block.
This is some text inside of a div block.
This is some text inside of a div block.
This is some text inside of a div block.
This is some text inside of a div block.
This is some text inside of a div block.
This is some text inside of a div block.
This is some text inside of a div block.
This is some text inside of a div block.
This is some text inside of a div block.